580_PR: Clinical and demographic features that influence EGFR mutation detection in plasma from patients (pts) with aNSCLC: The ASSESS experience

Journal of Thoracic Oncology

Volumn 11, Issue 4, 2016, Pages S151-

  Normanno, N ^a   Brown, H ^b   Haddad, V ^b   Ratcliffe, M ^b   McCormack, R ^b   Tjulandin, S ^c   Hagiwara, K ^d   Han, B ^e   Reck, M ^f  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b ASTRAZENECA   (United Kingdom)

^c N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e SHANGHAI JIAO TONG UNIVERSITY   (China)

^f Onkologischer Schwerpunkt   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; EGFR GENE; ETHNICITY; EUROPE; GENDER; GENE IDENTIFICATION; GENE MUTATION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; METASTASIS; NON SMALL CELL LUNG CANCER; PLASMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SMOKING; WORLD HEALTH ORGANIZATION;

EID: 85012902207     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/S1556-0864(16)30323-9     Document Type: Article

References (0)